Gyöngyvér Szentmártoni

Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations

David N. Brown, Dominiek Smeets, Borbála Székely et al. · Nature Communications · 2017 · 190 citations · Full text

Medicine, Genetics, Oncology +17

Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy

Balázs Ács, Veronika Zámbó, Laura Vízkeleti et al. · Diagnostic Pathology · 2017 · 99 citations · Full text

Medicine, Biostatistics, Oncology +17

Predictive and prognostic value of FDG-PET/CT imaging and different response evaluation criteria after primary systemic therapy of breast cancer

Tímea Tőkés, Kornélia Kajáry, Gyöngyvér Szentmártoni et al. · Breast Cancer · 2016 · 20 citations

Medicine, Oncology, Radiology +17

Prognostic and Clinicopathological Correlations of Cell Cycle Marker Expressions before and after the Primary Systemic Therapy of Breast Cancer

Tímea Tőkés, Anna-Mária Tőkés, Gyöngyvér Szentmártoni et al. · Pathology & Oncology Research · 2019 · 18 citations · Full text

Medicine, Cell Biology, Oncology +17

Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid Tumors

Gyöngyvér Szentmártoni, Dorottya Mühl, Renata Csanda et al. · Biomedicines · 2024 · 13 citations · Full text

Medicine, Molecular Genetics, Oncology +17